Consistently, silencing of MYH9 significantly inhibited tumor growth, angiogenesis, EMT, and β‐catenin expression in animal models that were generated using SAMD9 overexpressing ESCC cells (Figure 5g). This evidence concerns the gene MYH9 and esophageal squamous cell carcinoma.